J. B. Chemicals & Pharmaceuticals Limited (BOM:506943)
India flag India · Delayed Price · Currency is INR
1,892.70
-12.05 (-0.63%)
At close: Feb 13, 2026

BOM:506943 Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
41,93039,18034,84231,49324,24220,425
Revenue Growth (YoY)
9.47%12.45%10.63%29.91%18.69%15.09%
Cost of Revenue
13,81613,54512,14211,9638,6557,227
Gross Profit
28,11525,63522,70019,53015,58813,198
Selling, General & Admin
9,8049,1728,1117,2785,6624,258
Other Operating Expenses
6,9916,1535,6615,1904,4603,358
Operating Expenses
18,58417,03515,15613,61210,8498,303
Operating Income
9,5308,6007,5445,9184,7394,895
Interest Expense
-47.05-106.45-436.52-347.68-40.85-67.43
Interest & Investment Income
53.3153.3144.2625.399.3917.79
Currency Exchange Gain (Loss)
7.187.1844.07-110.87-38.0142.34
Other Non Operating Income (Expenses)
238.58-4.72-5.79-2.791.0650.88
EBT Excluding Unusual Items
9,7838,5507,1905,4824,6714,939
Gain (Loss) on Sale of Investments
322.08322.08327.4369350.43505.5
Gain (Loss) on Sale of Assets
2.122.12-2.320.0724.05524.37
Other Unusual Items
---1.283.98-
Pretax Income
10,1078,8747,5155,5525,0495,969
Income Tax Expense
2,5692,2781,9891,4521,1891,484
Earnings From Continuing Operations
7,5386,5965,5264,1003,8604,485
Minority Interest in Earnings
----1.7-6.82-5.59
Net Income
7,5386,5965,5264,0983,8544,480
Net Income to Common
7,5386,5965,5264,0983,8544,480
Net Income Growth
17.77%19.35%34.84%6.35%-13.98%64.66%
Shares Outstanding (Basic)
156155155155155155
Shares Outstanding (Diluted)
159159159157155155
Shares Change (YoY)
-0.27%0.07%1.26%1.23%0.10%-2.86%
EPS (Basic)
48.2942.4535.6626.5024.9328.98
EPS (Diluted)
47.4741.5634.8526.1724.9128.98
EPS Growth
18.07%19.25%33.17%5.06%-14.04%69.50%
Free Cash Flow
-8,0496,7375,5621,0732,670
Free Cash Flow Per Share
-50.7242.4835.516.9317.27
Dividend Per Share
19.70015.50012.2508.8758.2508.250
Dividend Growth
29.18%26.53%38.03%7.58%-50.00%
Gross Margin
67.05%65.43%65.15%62.01%64.30%64.62%
Operating Margin
22.73%21.95%21.65%18.79%19.55%23.97%
Profit Margin
17.98%16.84%15.86%13.01%15.90%21.93%
Free Cash Flow Margin
-20.54%19.34%17.66%4.42%13.07%
EBITDA
11,35710,1888,8137,0385,3845,498
EBITDA Margin
27.09%26.00%25.30%22.35%22.21%26.92%
D&A For EBITDA
1,8271,5881,2691,120645.45602.84
EBIT
9,5308,6007,5445,9184,7394,895
EBIT Margin
22.73%21.95%21.65%18.79%19.55%23.97%
Effective Tax Rate
25.42%25.67%26.46%26.16%23.54%24.86%
Revenue as Reported
42,55739,56335,21431,59224,63521,549
Advertising Expenses
-2,2732,0771,8081,250838.21
Source: S&P Global Market Intelligence. Standard template. Financial Sources.